Trending Now
Business
Trump Will Whip The Coronavirus Like He Whipped Hillary
Last week reports suggested President Trump contracted the coronavirus. The President has insisted on having press conferences without masks, holding rallies without masks and...
Texas AG Ken Paxton Reaches Deal Distribute Opioid Funds
The opioid epidemic continues to dominate the public discourse. The question remains, "What can be done about it?" The number of accidental deaths related...
Lifestyle today
Entertainment
Morgan Stanley Believes Trump’s Next Threat Could Trigger Global Recession
Uncertainty over the trade war prompted Federal Reserve Chairman Jerome Powell to cut interest rates to instill confidence within the business community. President Trump...
General Electric: Did ‘Run On The Bank’ Force A GECAS Sale?
Shares in General Electric (GE) spiked more than 6% Monday on market chatter that Apollo Global Management was interested in acquiring GE Capital Aviation...
Pelicans’ Demarcus Cousins Lost For The Season With Achilles Injury
The New Orleans Pelicans upended the Houston Rockets Friday night 115-113. It was a huge win and confidence booster for the Pelicans. Anthony Davis...
Shock Exchange, ‘Cutty’ From HBO’s ‘The Wire’ Collab In Brooklyn February 6th
HBO's The Wire has developed a cult following. I watched the show religiously from the very beginning. I remember staying up past midnight on...
IBM: Q4 Results Will Not Change The Narrative
IBM (IBM) reports quarterly earnings January 22nd. Analysts expect revenue of $21.8 billion and eps of $4.84. The revenue estimate implies double-digit growth Y/Y....
Allergan: Et Tu, Novartis?
Last week Allergan (AGN) lost an appeal in its attempt to protect its Combigan eye drug from generic competition posed by Novartis AG's (NVS),...
BlackRock’s Larry Fink Maintains Colossal Bet On Endo
Heading into Q3 2018 earnings Endo International (ENDP) had been one of the market's hottest stocks. The stock had more than doubled heading into...
Valeant’s Talc / Ovarian Cancer Exposures Could Spell Major Trouble
Last week a California jury dropped a talc bombshell on Johnson & Johnson (JNJ), awarding $417 million to a 63-year old woman who claimed...
























































































































